Companies receiving funding or being acquired.
On February 12, 2025, the Canadian government announced a significant investment of $2 million in FluidAI Medical, facilitated by the…
FluidAI Medical Secures $2 Million Funding from Canadian Government KITCHENER, ON, July 9, 2025 – FluidAI Medical has been awarded…
Summary of Cobionix Funding Announcement and CODI® Deployment Cobionix, a pioneering company in autonomous medical robotics based in Kitchener, Ontario,…
Banyan Software Acquires HR4 Ltd. Banyan Software, a prominent acquirer and permanent home for enterprise software businesses, has announced its…
Toronto-based startup Xatoms has developed an innovative method to purify contaminated water using just sunlight and a photocatalytic powder. This…
Trackunit Secures Investment from Goldman Sachs Alternatives and Hg On June 16, 2025, Trackunit, a leader in software and IoT…
Two London-based startups have each secured $500,000 from the Ontario government to advance their innovative technologies. The first recipient is…
Summary of Business Combination Announcement On June 12, 2025, 1317229 B.C. Ltd. (referred to as "131"), along with Launchit Solutions…
Ontario Government’s Investment in Life Sciences Innovation On June 9, 2025, the Ontario government announced a significant investment of $6.5…
Donnager AI officially launched in Toronto’s bustling AI startup ecosystem, aiming to tackle a significant challenge for founders: creating personalized…
The 2025 Synapse Life Science Competition, hosted by Innovation Factory on March 26, showcased five promising life science startups competing…
On March 19, 2025, the TechAlliance of Southwestern Ontario held its inaugural Polaris Pitch Competition at the London Music Hall,…
Discover how Afynia Laboratories secured a $5 million seed round to commercialize its microRNA panel test for endometriosis.Discover how Afynia Laboratories secured a $5 million seed round to commercialize its microRNA panel test for endometriosis.
Lactiga, a biotechnology company based in North Brunswick, N.J., specializes in developing therapies using naturally occurring antibodies for inflammatory and…
In an article published by Daniella Fiorentino from the Office of the VP Research at McMaster University on February 24,…
On February 25, 2025, Paradox Immunotherapeutics, a Toronto-based pharmaceutical company dedicated to developing innovative antibody therapies for protein misfolding diseases,…
Monerus took home the $20,000 grand prize at WEtechAlliance’s ScaleUP Showcase & Pitch Competition, marking a significant milestone for…
Enhanced Medical Nutrition, Inc. (EMN), a Toronto-based food-as-medicine company, recently announced a successful $5 million over-subscribed Series A financing round…
Waterloo-based VueReal has successfully raised US$40.5 million in a Series C funding round with plans to scale up its production…
With the Invictus Games fast approaching in Vancouver, Sydney Robinson, CEO and co-founder of Vessl Prosthetics, views the timing as…
This website uses cookies to save your preferences, and track popular pages. Cookies ensure we do not require visitors to register, login, or share any identity information.